Literature DB >> 32779974

Mitigation of Aerosols Generated During Rhinologic Surgery: A Pandemic-Era Cadaveric Simulation.

Dhruv Sharma1,2, Michael J Ye1,2, Vincent J Campiti2, Kolin E Rubel1,2, Thomas S Higgins3,4, Arthur W Wu5, Taha Z Shipchandler1, Michael W Sim1, Sarah J Burgin1, Elisa A Illing1, Jae Hong Park6, Jonathan Y Ting1.   

Abstract

OBJECTIVE: After significant restrictions initially due to the COVID-19 pandemic, otolaryngologists have begun resuming normal clinical practice. However, the risk of SARS-CoV-2 transmission to health care workers through aerosolization and airborne transmission during rhinologic surgery remains incompletely characterized. The objective of this study was to quantify the number concentrations of aerosols generated during rhinologic surgery with and without interventions involving 3 passive suction devices. STUDY
DESIGN: Cadaver simulation.
SETTING: Dedicated surgical laboratory. SUBJECTS AND METHODS: In a simulation of rhinologic procedures with and without different passive suction interventions, the concentrations of generated aerosols in the particle size range of 0.30 to 10.0 µm were quantified with an optical particle sizer.
RESULTS: Functional endoscopic sinus surgery with and without microdebrider, high-speed powered drilling, use of an ultrasonic aspirator, and electrocautery all produced statistically significant increases in concentrations of aerosols of various sizes (P < .05). Powered drilling, ultrasonic aspirator, and electrocautery generated the highest concentration of aerosols, predominantly submicroparticles <1 µm. All interventions with a suction device were effective in reducing aerosols, though the surgical smoke evacuation system was the most effective passive suction method in 2 of the 5 surgical conditions with statistical significance (P < .05).
CONCLUSION: Significant aerosol concentrations were produced in the range of 0.30 to 10.0 µm during all rhinologic procedures in this cadaver simulation. Rhinologic surgery with a passive suction device results in significant mitigation of generated aerosols.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; aerosol particles; aerosol-generating procedure; airborne; endonasal drilling; sinus surgery; skull base surgery

Year:  2020        PMID: 32779974      PMCID: PMC7424621          DOI: 10.1177/0194599820951169

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  6 in total

1.  COVID-19 and rhinological surgery.

Authors:  Rushi Patel; Christina H Fang; Jordon G Grube; Jean Anderson Eloy; Wayne D Hsueh
Journal:  Oper Tech Otolayngol Head Neck Surg       Date:  2022-04-28

2.  Reducing the risks of endoscopic sinonasal surgery in the Covid-19 era.

Authors:  Samuel C Leong; Dilesh Mogre; Peter Andrews; Elgan Davies
Journal:  Clin Otolaryngol       Date:  2021-03-10       Impact factor: 2.729

3.  Evaluation of the aerosol generating potential of endoscopic dacryocystorhinostomy.

Authors:  Darren A Chen; Mark Lee; Gary J Lelli; Ashutosh Kacker
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-08-17

4.  Aerosol Generation During Otologic Surgery.

Authors:  Mari Lahelma; Lotta Oksanen; Noora Rantanen; Saku Sinkkonen; Antti Aarnisalo; Ahmed Geneid; Enni Sanmark
Journal:  Otol Neurotol       Date:  2022-07-28       Impact factor: 2.619

5.  Aerosol generation during routine rhinologic surgeries and in-office procedures.

Authors:  Dhruv Sharma; Vincent J Campiti; Michael J Ye; Kolin E Rubel; Thomas S Higgins; Arthur W Wu; Taha Z Shipchandler; Sarah J Burgin; Michael W Sim; Elisa A Illing; Jae Hong Park; Jonathan Y Ting
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-01-14

6.  Aerosol generation during cadaveric simulation of otologic surgery and live cochlear implantation.

Authors:  Dhruv Sharma; Vincent J Campiti; Michael J Ye; Mohamad Saltagi; Aaron E Carroll; Jonathan Y Ting; Elisa A Illing; Jae Hong Park; Rick F Nelson; Sarah J Burgin
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-12-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.